AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

9 registrations across 4 African markets— 8 active

Markets with EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Emtricitabine and Tenofovir Disoproxil fumarate Tablets 200mg /300 mg
TABLETS
🇷🇼RwandaHETERO LABS LIMITEDactiveAug 2029
AVIRODAY
Film-Coated Tablet
🇰🇪KenyaSUN PHARMACEUTICAL INDUSTRIES LIMITEDactiveNov 2027
EMTRICITABINE_AND_TENOFOVIR_DISOPROXIL_FUMARATE 200/300MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
Emtricitabine and Tenofovir Disoproxil Fumarate tablets 200 mg/ 300 mg
Tablet, Film-coated
🇹🇿TanzaniaLAURUS LABS LIMITEDactive
Emtricitabine/ Tenofovir Disoproxil Fumarate
Film Coated Tablet
🇹🇿TanzaniaSHANGHAI DESANO BIO-PHARMACEUTICAL Co., LTD.,active
Emtricitabine and Tenofovir Disoproxil Fumarate
Tablets
🇹🇿TanzaniaHetero Labs Limitedactive
Descovy
Tablet, Film-coated
🇹🇿TanzaniaGilead Sciences, Incactive
Emtricitabine and Tenofovir Disoproxil Fumarate
Tablet, Film-coated
🇹🇿TanzaniaSun Pharmaceutical Industries Ltdactive
Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300 mg
Tablets
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE in Africa — Regulatory Overview

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.